Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

NKTX


Fundamental

Company: Nkarta Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -1.41
Insider Own: 24.55%
Shs Outstand: 71.08M
Perf Week: -6.47%
Market Cap: 154.70M
Forward P/E: -
EPS next Y: -1.42
Insider Trans: -0.18%
Shs Float: 53.79M
Perf Month: -10.70%
Enterprise Value: -45.16M
PEG: -
EPS next Q: -0.35
Inst Own: 64.38%
Short Float: 10.28%
Perf Quarter: 2.84%
Income: -104.08M
P/S: -
EPS this Y: -2.70%
Inst Trans: -2.62%
Short Ratio: 7.69
Perf Half Y: 3.83%
Sales: 0.00M
P/B: 0.49
EPS next Y Percentage: 2.00%
ROA: -22.66%
Short Interest: 5.53M
Perf YTD: 17.30%
Book/sh: 4.39
P/C: 0.56
EPS next 5Y: 4.00%
ROE: -28.90%
52W High: 2.81 -22.78%
Perf Year: 41.83%
Cash/sh: 3.88
P/FCF: -
EPS past 3/5Y: 18.61% 23.69%
ROIC: -27.26%
52W Low: 1.48 46.62%
Perf 3Y: -39.72%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: - -
Gross Margin: -
Volatility W: 6.17%
Volatility M: 6.20%
Perf 5Y: -93.28%
Dividend TTM: -
EV/Sales: -
EPS Y/Y TTM: 15.26%
Oper. Margin: -
ATR (14): 0.16
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 12.69
Sales Y/Y TTM: -
Profit Margin: -
RSI (14): 46.16
Recom: 1.00
Dividend Gr. 3/5Y: - -
Current Ratio: 12.69
EPS Q/Q: -5.05%
SMA20: -1.41%
Beta: 0.72
Target Price: 11.60
Payout: -
Debt/Eq: 0.24
Sales Q/Q: -
SMA50: -4.43%
Rel Volume: 1.11
Prev Close: 2.34
Employees: 108
LT Debt/Eq: 0.22
Earnings: Mar 25 AMC
SMA200: 3.69%
Avg Volume: 719.12K
Price: 2.17
IPO: Jul 10, 2020
Option/Short: Yes / Yes
EPS/Sales Surpr.: -19.35% -
Trades:
Volume: 795,990
Change: -7.26%

Technical:


Latest News:

Cullinan stock rises on Amgen's Blincyto data (NASDAQ:CGEM) | Seeking Alpha very bullish
CGEM AMGN ADCT ALLO AZN AUTL BMY IPSC GILD MOR NKTX NVS

Summary: Cullinan Therapeutics (CGEM) stock surged ~58% last week after positive data for CD19-targeting therapy similar to competitor Amgen's Blincyto, showing efficacy against autoimmune diseases like rheumatoid arthritis and systemic sclerosis.

Full article
2024-04-27T19:44:12Z